Published: March 5, 2025 Unified Patent Court’s first decision on infringement by equivalence A recent decision by a Court of First Instance of the Unified Patent Court (UPC) has set out...
Published: February 5, 2025 G2/24 – Can intervening infringers gain “appellant” status? The Enlarged Board of Appeal will decide upon the status granted to intervening infringers in Appeal proceedings, which...
Published: February 5, 2025 UK Court of Appeal blocks the potential for UK second medical use SPCs No second medical use SPCs in the UK As reported previously, following an appeal lodged by Merck Serono...
Published: January 7, 2025 Forresters client receives OBE in New Year’s Honours list We are delighted to learn that Dr Tom Balchin, a long-standing client of Forresters, has been made an...
Published: December 13, 2024 UK Supreme Court set to rule on patentability of AI The UK Supreme Court has granted Emotional Perception AI permission to appeal a decision of the UK Court of...
Published: October 29, 2024 T56/21 – No legal basis for description adaptation at the EPO The EPO’s insistence that the description be amended to conform to the claims (“description adaptation”) before a European...
Published: October 18, 2024 Intervent Cardio win 2024 TBAT Innovation Challenge Intervent Cardio was crowned the winner of the 2024 TBAT Innovation Challenge, sponsored by Forresters. Intervent Cardio has...
Published: October 17, 2024 When is a second medical use claim not a second medical use claim? A recent decision by an EPO Board of Appeal provides guidance on drafting claims to the therapeutic use...
Published: September 24, 2024 G2/21: Life after the decision In G2/21, the Enlarged Board of Appeal (EBA) clarified when a technical effect can be used to support...
Published: September 5, 2024 T 2360/19 further confirms the EPO’s U-turn regarding the standard for assessing the legal right to claim priority In our previous article, we outlined how the Enlarged Board of Appeal decisions G1/22 and G/22 indicated that...
Published: August 30, 2024 The EPO relaxes the standard for assessing the legal right to claim priority At the end of 2023, the Enlarged Board of Appeal (EBA) at the EPO issued its decision on...
Published: August 29, 2024 Potential for second medical use SPCs in the UK? The ability to obtain SPCs in Europe to extend patents for new therapeutic uses of known products, i.e....
